{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T08:00:05Z","timestamp":1785571205819,"version":"3.56.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K23DA046482"],"award-info":[{"award-number":["K23DA046482"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20 GM125507"],"award-info":[{"award-number":["P20 GM125507"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.jsat.2021.108538","type":"journal-article","created":{"date-parts":[[2021,6,15]],"date-time":"2021-06-15T23:11:56Z","timestamp":1623798716000},"page":"108538","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Feasibility and acceptability of a digital health intervention to promote engagement in and adherence to medication for opioid use disorder"],"prefix":"10.1016","volume":"131","author":[{"given":"Kirsten J.","family":"Langdon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Scherzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Ramsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Carey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josiah","family":"Rich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan L.","family":"Ranney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jsat.2021.108538_bb0005","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1080\/08897077.2019.1640833","article-title":"Underutilization of medications to treat opioid use disorder: What role does stigma play?","volume":"40","author":"Allen","year":"2019","journal-title":"Substance Abuse"},{"key":"10.1016\/j.jsat.2021.108538_bb0015","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1037\/a0037496","article-title":"Adding an internet-delivered treatment to an efficacious treatment package for opioid dependence","volume":"82","author":"Christensen","year":"2014","journal-title":"Journal of Consulting and Clinical Psychology"},{"issue":"4","key":"10.1016\/j.jsat.2021.108538_bb0020","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1080\/08897077.2016.1176980","article-title":"Factors associated with patterns of mobile technology use among persons who inject drugs","volume":"37","author":"Collins","year":"2016","journal-title":"Substance Abuse"},{"issue":"10","key":"10.1016\/j.jsat.2021.108538_bb0025","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1056\/NEJMoa022164","article-title":"Office-based treatment of opiate addiction with a sublingual tablet formulation of buprenorphine and naloxone","volume":"349","author":"Fudala","year":"2003","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.jsat.2021.108538_bb0030","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/1471-2288-13-117","article-title":"Using the framework method for the analysis of qualitative data in multidisciplinary health research","volume":"13","author":"Gale","year":"2013","journal-title":"BMC Medical Research Methodology"},{"key":"10.1016\/j.jsat.2021.108538_bb0035","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/her\/cyt094","article-title":"Exploring the feasibility of text messaging to support substance abuse recovery among youth in treatment","volume":"29","author":"Gonzales","year":"2014","journal-title":"Health Education Research"},{"key":"10.1016\/j.jsat.2021.108538_bb0040","unstructured":"GSMA Intelligence (2019). The State of Mobile Internet Connectivity."},{"issue":"16","key":"10.1016\/j.jsat.2021.108538_bb0045","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1001\/jama.2020.18543","article-title":"The opioid epidemic during the COVID-19 pandemic","volume":"324","author":"Haley","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.jsat.2021.108538_bb0050","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.socscimed.2013.08.003","article-title":"Efficacy of text message-based interventions for health promotion: A meta-analysis","volume":"97","author":"Head","year":"2013","journal-title":"Social Science & Medicine"},{"key":"10.1016\/j.jsat.2021.108538_bb0055","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/add.12333","article-title":"Treatment retention among patients randomized to buprenorphine\/naloxone compared to methadone in a multi-site trial","volume":"109","author":"Hser","year":"2014","journal-title":"Addiction"},{"issue":"9358","key":"10.1016\/j.jsat.2021.108538_bb0060","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0140-6736(03)12600-1","article-title":"1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: A randomised, placebo-controlled trial","volume":"361","author":"Kakko","year":"2003","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.jsat.2021.108538_bb0065","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13722-020-00189-4","article-title":"Development of an integrated digital health intervention to promote engagement in and adherence to medication for opioid use disorder","volume":"15","author":"Langdon","year":"2020","journal-title":"Addiction Science & Clinical Practice"},{"key":"10.1016\/j.jsat.2021.108538_bb0070","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/s41386-020-0761-5","article-title":"Digital health data-driven approaches to understand human behavior","volume":"46","author":"Marsch","year":"2020","journal-title":"Neuroopsychopharmacol"},{"key":"10.1016\/j.jsat.2021.108538_bb0075","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s11121-014-0498-7","article-title":"Text messaging interventions for adolescent and young adult substance use: A meta-analysis","volume":"16","author":"Mason","year":"2015","journal-title":"Prevention Science"},{"key":"10.1016\/j.jsat.2021.108538_bb0080","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","volume":"2","author":"Mattick","year":"2014","journal-title":"The Cochrane Database of Systematic Reviews"},{"issue":"2","key":"10.1016\/j.jsat.2021.108538_bb0085","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1080\/23288604.2019.1583040","article-title":"Digital technology and the future of health systems","volume":"5","author":"Mitchell","year":"2019","journal-title":"Health Systems & Reform"},{"key":"10.1016\/j.jsat.2021.108538_bb0090","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1037\/a0029963","article-title":"Developing a theory driven text messaging intervention for addiction care with user driven content","volume":"27","author":"Muench","year":"2013","journal-title":"Psychology of Addictive Behaviors"},{"key":"10.1016\/j.jsat.2021.108538_bb0095","series-title":"Medications for Opioid Use Disorder Save Lives","author":"National Academies of Sciences, Engineering, and Medicine","year":"2019"},{"key":"10.1016\/j.jsat.2021.108538_bb0100","doi-asserted-by":"crossref","unstructured":"O'Donnell J., Gladden, R.M., Mattson, C.L., Hunter, C.T., Davis, N.L. (2020). Vital signs: Characteristics of drug overdose deaths involving opioids and stimulants: 24 states and the District of Columbia, January\u2013June 2019, MMWR. Morbidity and Mortality Weekly Report, 69(35), 1189\u20131197. http:\/\/dx.doi.org\/10.15585\/mmwr.mm6935a1external icon.","DOI":"10.15585\/mmwr.mm6935a1"},{"issue":"1","key":"10.1016\/j.jsat.2021.108538_bb3105","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jadohealth.2013.12.017","article-title":"Acceptability, language, and structure of text message-based behavioral interventions for high-risk adolescent females: A qualitative study","volume":"55","author":"Ranney","year":"2014","journal-title":"The Journal of Adolescent Health"},{"key":"10.1016\/j.jsat.2021.108538_bb0105","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jadohealth.2016.04.008","article-title":"A depression prevention intervention for adolescents in the emergency department","volume":"59","author":"Ranney","year":"2016","journal-title":"The Journal of Adolescent Health"},{"issue":"4","key":"10.1016\/j.jsat.2021.108538_bb0110","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1037\/ser0000193","article-title":"Emergency department text messaging for adolescent violence and depression prevention: A pilot randomized controlled trial","volume":"15","author":"Ranney","year":"2018","journal-title":"Psychological Services"},{"key":"10.1016\/j.jsat.2021.108538_bb0115","series-title":"Qualitative research practice: A guide for social science students and researchers","author":"Ritchie","year":"2013"},{"key":"10.1016\/j.jsat.2021.108538_bb0120","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.beth.2011.01.003","article-title":"A pilot study of the DBT coach: An interactive mobile phone application for individuals with borderline personality disorder and substance use disorder","volume":"42","author":"Rizvi","year":"2011","journal-title":"Behavior Therapy"},{"key":"10.1016\/j.jsat.2021.108538_bb3125","unstructured":"Substance Abuse and Mental Health Services Administration (2019). https:\/\/www.samhsa.gov\/medication-assistedtreatment."},{"key":"10.1016\/j.jsat.2021.108538_bb0125","series-title":"Smartphone ownership is growing rapidly around the world, but not always equally","author":"Silver","year":"2019"},{"key":"10.1016\/j.jsat.2021.108538_bb0130","doi-asserted-by":"crossref","first-page":"52","DOI":"10.7748\/nr2011.01.18.2.52.c8284","article-title":"Qualitative data analysis: The framework approach","volume":"18","author":"Smith","year":"2011","journal-title":"Nurse Researcher"},{"key":"10.1016\/j.jsat.2021.108538_bb0135","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jsat.2010.05.014","article-title":"Antidepressant treatment does not improve buprenorphine retention among opioid-dependent persons","volume":"39","author":"Stein","year":"2010","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"11","key":"10.1016\/j.jsat.2021.108538_bb0145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002969","article-title":"Stigma as a fundamental hindrance to the United States opioid overdose crisis response","volume":"16","author":"Tsai","year":"2019","journal-title":"PLoS Medicine"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547221002646?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547221002646?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:55:48Z","timestamp":1760039748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547221002646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":29,"alternative-id":["S0740547221002646"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2021.108538","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Feasibility and acceptability of a digital health intervention to promote engagement in and adherence to medication for opioid use disorder","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2021.108538","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108538"}}